Any feedback?
Literature summary for 3.4.21.7 extracted from
- Plasmin therapy enhances mobilization of HPCs after G-CSF (2008), Blood, 112, 4048-4050.
Protein Variants
| Protein Variants | Comment | Organism |
|---|---|---|
| additional information | mice homozygotically lacking the plasminogen inhibitor Pai-1 or the plasmin inhibitor alpha2-antiplasmin show an increase in hematopoietic progenitor cell mobilization in response to granulocyte colony-stimulating factor | Mus musculus |
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | Mus musculus | role for plasmin in augmenting hematopoietic progenitor cell mobilization in response to granulocyte colony-stimulating factor | ? | - |
? |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | role for plasmin in augmenting hematopoietic progenitor cell mobilization in response to granulocyte colony-stimulating factor | Mus musculus | ? | - |
? | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
